Nucleus Basalis of Meynert Neurons

📖 Wiki Page

cell1117 wordssynced 2026-04-02

Nucleus Basalis of Meynert Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus Basalis of Meynert Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:2000056](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_2000056)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Percentage</td>
</tr>
<tr>
<td class="label">Large cholinergic projection neurons</td>
<td>~90%</td>
</tr>
<tr>
<td class="label">GABAergic interneurons</td>
<td>~5-7%</td>
</tr>
<tr>
<td class="label">Non-cholinergic projection neurons</td>
<td>~3-5%</td>
</tr>
<tr>
<td class="label">Group</td>
<td>Location</td>
</tr>
<tr>
<td class="label">Ch1</td>
<td>Septal nuclei</td>
</tr>
<tr>
<td class="label">Ch2</td>
<td>Vertical diagonal band</td>
</tr>
<tr>
<td class="label">Ch3</td>
<td>Horizontal diagonal band</td>
</tr>
<tr>
<td class="label">Ch4</td>
<td>Nucleus basalis of Meynert</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">CHAT</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">SLC18A3 (VAChT)</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">NTRK1 (TrkA)</td>
<td>High</td>
</tr>
<tr>
<td class="label">NGFR (p75NTR)</td>
<td>High</td>
</tr>
<tr>
<td class="label

...

Nucleus Basalis of Meynert Neurons

Introduction

Nucleus Basalis Of Meynert Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Pathway Diagram

Mermaid diagram (expand to render)

Knowledge graph relationships for NUCLEUS (471 total edges in KG)

Overview

The Nucleus Basalis of Meynert (NBM) is the major cholinergic output nucleus of the basal forebrain, providing the primary source of acetylcholine to the neocortex[@mesulam1983]. These neurons are essential for memory, attention, and cortical arousal, and their degeneration is a hallmark of Alzheimer's disease. The NBM is named after Meynert, who first described these large cholinergic neurons in the late 19th century.

The NBM contains approximately 200,000-250,000 cholinergic neurons in the healthy adult human brain, representing about 1-2% of the total neuronal population in the basal forebrain[@arendt1989]. These neurons project widely to the entire cortical mantle, with topographic organization reflecting different cortical areas.

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

[Cell Ontology (CL:2000056)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_2000056)
[OBO Foundry (CL:2000056)](http://purl.obolibrary.org/obo/CL_2000056)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)

Morphology and Markers

Neuron Types

Key Markers

Choline acetyltransferase (ChAT): Definitive cholinergic marker, synthesizes ACh
Vesicular acetylcholine transporter (VAChT): Packages ACh into vesicles
p75NTR (NGFR): Low-affinity NGF receptor, important for neuron survival
Acetylcholinesterase (AChE): Hydrolyzes ACh, termination of signaling
TrkA (NTRK1): High-affinity NGF receptor

Subdivisions (Cholinergic Cell Groups)

Normal Function

Cortical Cholinergic Modulation

The NBM provides widespread cholinergic innervation to the cortex[@sarter2005]:

Arousal and Attention: ACh enhances cortical processing of sensory information

Memory Consolidation: Hippocampal-cortical dialogue during sleep

Cortical Plasticity: ACh enables experience-dependent cortical reorganization

Signal-to-Noise Ratio: ACh enhances relevant signals while suppressing background

Neurophysiological Effects

Acetylcholine from NBM affects cortical neurons through:

Muscarinic receptors (m1-m5): Slow, modulatory effects
m1/m5: Excitatory, memory enhancement
m2/m4: Inhibitory, autoreceptor function
Nicotinic receptors (nAChRs): Fast, excitatory effects
α4β2: Most abundant in cortex
α7: Fast desensitizing, presynaptic modulation

Behavioral Functions

Attentional shifting: Flexibility in processing different stimulus features
Memory encoding: Formation of new associations
Sleep-wake transitions: Cortical activation during waking
Reward processing: Modulation of reinforcement learning

Disease Vulnerability

Alzheimer's Disease

The NBM is prominently affected in AD[@coyle2013]:

Early degeneration: Loss of 50-70% of NBM neurons in moderate AD
Neurofibrillary tangles: Found in NBM neurons in early stages
Amyloid deposition: Diffuse plaques in basal forebrain
Correlation with cognitive decline: Cholinergic loss predicts dementia severity

Parkinson's Disease and DLB

Incidental Lewy body disease: NBM vulnerability in PD
Cognitive impairment: Cholinergic deficits contribute to PD dementia
Cortical ACh reduction: More severe than in AD in some cases

Other Disorders

Progressive supranuclear palsy: Significant NBM loss
Corticobasal degeneration: Moderate cholinergic deficits
Schizophrenia: Reduced NBM volume in some studies

Transcriptomic Profile

Therapeutic Implications

Current Treatments

Acetylcholinesterase inhibitors: Donepezil, Rivastigmine, Galantamine

Increase synaptic ACh by inhibiting breakdown
Provide symptomatic benefit in AD and PDD

NMDA receptor antagonist: Memantine

Often combined with AChE inhibitors
Provides additional cognitive benefit

Investigational Approaches

Cholinergic neuron transplantation: Early trials showed promise

NGF gene therapy: AAV-NGF delivery to NBM (failed in clinical trials)

Selective muscarinic agonists: Targeting specific receptor subtypes

Nicotinic modulators: α7 and α4β2 selective compounds

Biomarkers

NBM integrity can be assessed through:

MRI: Basal forebrain volume measurement
PET: Muscarinic and nicotinic receptor binding
CSF: Cholinergic markers (ChAT activity, ACh levels)

Animal Models

Rodent Studies

ChAT-Cre mice: Genetic access to cholinergic neurons
NGF knockout: Severe basal forebrain degeneration
Lesion models: ibotenic acid, 192-IgG-saporin

Key Findings

NGF is essential for cholinergic neuron survival
ACh release correlates with attention task performance
Cortical ACh enhancement improves memory in aged animals

Research Directions

Emerging Areas

Circuit-specific neuromodulation: Optogenetic control of NBM-cortex pathways

Neuroprotection: NGF, BDNF, and related trophic factors

Stem cell approaches: Cholinergic neuron replacement

Gene therapy: Viral vector delivery of trophic factors

Key Publications

[1] Mesulam MM, et al. Cholinergic neurons of the nucleus basalis and their telencephalic targets. J Comp Neurol. 1983;218(1):103-127. PMID: 6306066(https://pubmed.ncbi.nlm.nih.gov/6306066/)

[2] Arendt T, et al. The cholinergic system in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(5):715-728. PMID: 2682798(https://pubmed.ncbi.nlm.nih.gov/2682798/)

[3] Sarter M, et al. Unveiling the functions of the basal forebrain: commentary. Trends Neurosci. 2005;28(8):411-418. PMID: 15996651(https://pubmed.ncbi.nlm.nih.gov/15996651/)

[4] Coyle JT, et al. Alzheimer's disease: advancing toward a pharmacological cure. Mol Pharm. 2013;10(3):1131-1139. PMID: 24047414(https://pubmed.ncbi.nlm.nih.gov/24047414/)

[5] Hampel H, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain. 2019;142(7):e28. PMID: 31171408(https://pubmed.ncbi.nlm.nih.gov/31171408/)

[6] Baker-Nigh A, et al. Widespread neuronal accumulation of amyloid-beta in the basal forebrain. Acta Neuropathol. 2015;130(4):521-534. PMID: 26497982(https://pubmed.ncbi.nlm.nih.gov/26497982/)

[7] Schliebs R, et al. Basal forebrain cholinergic system in Alzheimer's disease: synaptic pathology and behavioral effects. Cell Mol Neurobiol. 2011;31(2):233-246. PMID: 21132342(https://pubmed.ncbi.nlm.nih.gov/21132342/)

[8] Haam J, et al. Cortical cholinergic signaling controls the detection of cues in a multisensory environment. Cell Rep. 2020;31(8):107580. PMID: 32402263(https://pubmed.ncbi.nlm.nih.gov/32402263/)

Background

The study of Nucleus Basalis Of Meynert Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

[Allen Cell Type Atlas](https://celltypes.brain-map.org/) - Cell type data and taxonomy
[Allen Brain Atlas API](https://api.brain-map.org/) - Gene expression and cell data
[BrainSpan Atlas](https://brainspan.org/) - Developmental brain gene expression

Pathway Diagram

The following diagram shows the key molecular relationships involving Nucleus Basalis of Meynert Neurons discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Nucleus Basalis of Meynert Neurons

Nucleus Basalis of Meynert Neurons

Introduction

Nucleus Basalis of Meynert Neurons

Introduction

Pathway Diagram

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

Morphology and Markers

Neuron Types

Key Markers

Subdivisions (Cholinergic Cell Groups)

Normal Function

Cortical Cholinergic Modulation

Neurophysiological Effects

Behavioral Functions

Disease Vulnerability

Alzheimer's Disease

Parkinson's Disease and DLB

Other Disorders

Transcriptomic Profile

Therapeutic Implications

Current Treatments

Investigational Approaches

Biomarkers

Animal Models

Rodent Studies

Key Findings

Research Directions

Emerging Areas

Key Publications

See Also

Background

Brain Atlas Resources

Pathway Diagram